Key Points - Courts have routinely observed that Medicare and Medicaid texts are among the most completely impenetrable texts within human experience. In.
On January 4, 2022, the District Court for the District of Delaware granted Hikma Pharmaceuticals USA Inc.’s (“Hikma”) motion to dismiss Amarin Pharma Inc.’s (“Amarin”) infringement.
Request to File Amended Complaint for Fraud Rejected for Failure to Allege Facts with Particularity | McGuireWoods LLP jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
To embed, copy and paste the code into your website or blog:
The U.S. Court of Appeals for the Federal Circuit’s New Year’s eve opinion in
Ball Metal v. Crown Packaging, though nonprecedential, raises important considerations for pharmaceutical and biologics patents – where patent challengers regularly allege the indefiniteness of “measurement” claim terms that describe pharmacologic or physicochemical properties of the invention. Under
Ball Metal, even if a “measurement” term is found to allow for multiple different measurement methods that can produce different results, indefiniteness may still be avoided if the challenger cannot show that such differences “matter for determining whether or not [the] claim limitation is met by those who might realistically be practicing the other claim limitations.”[i]